SHIH, David Q.,TARGAN, Stephan R.,LI, Dalin,BILSBOROUGH, Janine
申请号：
CL2015002866
公开号：
CL2015002866A1
申请日:
2015.09.25
申请国别(地区):
CL
年份:
2016
代理人:
摘要：
The invention relates to methods of treating fibrosis and inflammatory bowel disease. In one embodiment, the present invention treats gut inflammation by administering a therapeutically effective dosage of TL1A inhibitors and/or DR3 inhibitors to an individual. In another embodiment, the present invention provides a method of reversing tissue fibrosis in an individual by inhibiting TL1A-DR3 signaling function.LA INVENCIÓN PROPORCIONA UN TRATAMIENTO DE FIBROSIS E INFLAMACIÓN MEDIANTE LA INHIBICIÓN DE TL1A
